ACCP Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients - ACCP | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ACCP
2026
ACCP Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients
Document
Analyser ce document